Sumary of Using Lessons Learned from COVID-19 to Prepare for the Next Influenza Pandemic:
- This morning, the National Academy of Medicine (NAM) released 4 reports detailing how to leverage insights gained from COVID-19 the protect against future pandemics.
- The reports included information about utilizing COVID-19 vaccine technology in the development of influenza vaccines, reinforcing the influenza vaccine supply chain, improving global coordinated efforts, and taking advantage of non-vaccine public health measures (face masks, social distancing, etc.
- Influenza remains the pathogen most likely to cause the next pandemic, and estimates say it could be more devastating than the ongoing COVID-19 pandemic.
- Preparedness is essential, as the global cost of responding to a pandemic in 1 year is $570 billion, whereas investing ahead of time would cost approximately $4.5 billion annually.
- Dzau, President of the National Academy of Medicine, said, “COVID-19 has enabled the emergence of new capabilities, technologies, collaboration, and policies that could also be deployed before and during the next influenza pandemic.
- It’s critical to invest in science, strengthen health systems, and ensure trust in order to protect people from the health, social, and economic consequences of seasonal and pandemic influenza.
- ”Findings across the reports indicate that all countries should maintain continuous investment in vaccine technology, invest in supply chain forecasting, create manufacturing capacity in low- and middle-income countries, be inclusive of populations in research, and develop 4-8 billion doses of influenza vaccine to be distributed globally.
- Countering the Pandemic Threat through Global Coordination on Vaccines: The Influenza ImperativeThis report delineates the governance and financial measures to proactively develop vaccines before the outbreak of the next pandemic.